Phase 1 results support proceeding to Phase 2 in patients with post-bariatric hypoglycemia (PBH), which is expected to begin in 2H 2025 Phase 1 trial in healthy volunteers showed MBX 1416 was generall ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

In the MAD cohort, MBX 1416 appeared to increase GLP-1 within 60 minutes of a mixed meal tolerance test, suggesting a ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

The startup is developing macrocyles, which share strengths of both small molecules and biologics, as oral medicines against ...

The hydrogels acts as a stable reservoir, delivering medication in a regulated manner and sparing healthy cells.

That’s how I feel about Revision Skincare’s YouthFull Lip Replenisher, which I bought last month while on a mission to find ...

Researchers at IIT Guwahati and Bose Institute, Kolkata, have created an advanced injectable hydrogel for localized cancer ...

A research team has developed an innovative injectable adhesive hydrogel for bone regeneration. This hydrogel utilizes ...

In preclinical trials on a murine model of breast cancer, the hydrogel showcased remarkable efficacy, the scientists said.

Researchers have developed an injectable adhesive hydrogel for bone regeneration that uses light for cross-linking.

The developed hydrogel-based therapy delivers anti-cancer drugs directly to tumor sites and after completion of the ongoing ...